| Vol. 16.01 – 12 January, 2024 |
| |
|
|
| The authors found that mice harboring the microbiota of wild-caught mice developed overt colitis following treatment with anti-cytotoxic T-lymphocyte protein 4 (CTLA-4) antibodies. [Science] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Combining Kaede photoconvertible mice and single-cell genomics, investigators generated a detailed map of migratory trajectories from the colon, at baseline, and in several models of intestinal and extraintestinal inflammation. [Science Immunology] |
|
|
|
| By performing single-cell RNA sequencing in colorectal cancer tissues, researchers found tumor-associated macrophages and granulocytic myeloid-derived suppressor cells increased most compared to their counterparts in normal tissue. [Nature Cancer] |
|
|
|
| A twindrive precise delivery system of hybrid membrane combined with CD47 blocking was developed for targeted delivery and targeted regulation to induce postoperative immunotherapy. [ACS Nano] |
|
|
|
| Scientists identified a conserved signaling cascade that led to Hippo pathway activation by innate immune/inflammatory signals. [Nature Communications] |
|
|
|
| Researchers revealed that the impact of Eomes on effector CD4+ T cell longevity was associated with sustained expression of multiple genes involved in mitochondrial organization and functions. [Journal Of Experimental Medicine] |
|
|
|
| The authors discovered that blocking the PI3Kδ pathway pharmaceutically to varying degrees could generate T cells with increasingly heightened stemness properties, based on the progressive enrichment of the transcription factors Tcf1 and Lef1. [Cancer Research] |
|
|
|
| Investigators elucidated the underlying mechanism of Ars. alb 30C-mediated immune priming in murine macrophage cell line. [Scientific Reports] |
|
|
|
|
| The authors discuss the interplay between myeloid-derived suppressor cells (MDSCs) and various other cell types found in tumors as well as the mechanisms by which MDSCs promote tumor progression. [Nature Reviews Clinical Oncology] |
|
|
|
|
| The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $5.8 million to work toward easier diagnosis and better treatment options for Sjögren’s disease, an autoimmune condition. [Oklahoma Medical Research Foundation] |
|
|
|
|
| February 14 – 16, 2024 Lorne, Australia |
|
|
|
|
|
| University of Illinois at Chicago College of Medicine – Chicago, Illinois, United States |
|
|
|
| Northwestern University – Chicago, Illinois, United States |
|
|
|
| Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany |
|
|
|
| Francis Crick Institute – London, England, United Kingdom |
|
|
|
| Institut Pasteur – Paris, France |
|
|
|
|